183 related articles for article (PubMed ID: 29783641)
1. Premature Spinal Bone Loss in Women Living with HIV is Associated with Shorter Leukocyte Telomere Length.
Kalyan S; Pick N; Mai A; Murray MCM; Kidson K; Chu J; Albert AYK; Côté HCF; Maan EJ; Goshtasebi A; Money DM; Prior JC
Int J Environ Res Public Health; 2018 May; 15(5):. PubMed ID: 29783641
[TBL] [Abstract][Full Text] [Related]
2. Association between leukocyte telomere length and bone mineral density in women 25-93 years of age.
Nielsen BR; Linneberg A; Bendix L; Harboe M; Christensen K; Schwarz P
Exp Gerontol; 2015 Jun; 66():25-31. PubMed ID: 25868397
[TBL] [Abstract][Full Text] [Related]
3. Prolonged Amenorrhea and Low Hip Bone Mineral Density in Women Living With HIV-A Controlled Cross-sectional Study.
King EM; Nesbitt A; Albert AYK; Pick N; Cote HCF; Maan EJ; Prior JC; Murray MCM;
J Acquir Immune Defic Syndr; 2020 Apr; 83(5):486-495. PubMed ID: 31914005
[TBL] [Abstract][Full Text] [Related]
4. Deficits in bone strength, density and microarchitecture in women living with HIV: A cross-sectional HR-pQCT study.
Macdonald HM; Maan EJ; Berger C; Dunn RA; Côté HCF; Murray MCM; Pick N; Prior JC
Bone; 2020 Sep; 138():115509. PubMed ID: 32599222
[TBL] [Abstract][Full Text] [Related]
5. The age modification to leukocyte telomere length effect on bone mineral density and osteoporosis among Chinese elderly women.
Tao L; Huang Q; Yang R; Dai Y; Zeng Y; Li C; Li X; Zeng J; Wang Q
J Bone Miner Metab; 2019 Nov; 37(6):1004-1012. PubMed ID: 31025211
[TBL] [Abstract][Full Text] [Related]
6. Dynamics of leukocyte telomere length in pregnant women living with HIV, and HIV-negative pregnant women: A longitudinal observational study.
Saberi S; Kalloger SE; Zhu MMT; Sattha B; Maan EJ; van Schalkwyk J; Money DM; Côté HCF;
PLoS One; 2019; 14(3):e0212273. PubMed ID: 30840638
[TBL] [Abstract][Full Text] [Related]
7. Telomere length in leukocytes correlates with bone mineral density and is shorter in women with osteoporosis.
Valdes AM; Richards JB; Gardner JP; Swaminathan R; Kimura M; Xiaobin L; Aviv A; Spector TD
Osteoporos Int; 2007 Sep; 18(9):1203-10. PubMed ID: 17347788
[TBL] [Abstract][Full Text] [Related]
8. Long-Term Change in Bone Mineral Density in Women Living With HIV: A 10-Year Prospective Controlled Cohort Study.
Macdonald HM; Maan EJ; Berger C; Côte HCF; Murray MCM; Pick N; Prior JC;
JBMR Plus; 2023 Aug; 7(8):e10761. PubMed ID: 37614300
[TBL] [Abstract][Full Text] [Related]
9. Rate of dyslipidemia higher among women living with HIV: A comparison of metabolic and cardiovascular health in a cohort to study aging in HIV.
Russell E; Albert A; Côté H; Hsieh A; Nesbitt A; Campbell AR; Maan EJ; Brophy J; Pick N; Murray M
HIV Med; 2020 Aug; 21(7):418-428. PubMed ID: 32168418
[TBL] [Abstract][Full Text] [Related]
10. Associations between vitamin D metabolites, antiretroviral therapy and bone mineral density in people with HIV.
Klassen KM; Kimlin MG; Fairley CK; Emery S; Anderson PH; Ebeling PR;
Osteoporos Int; 2016 May; 27(5):1737-45. PubMed ID: 26659069
[TBL] [Abstract][Full Text] [Related]
11. Relative contribution of HIV infection, demographics and body mass index to bone mineral density.
Cotter AG; Sabin CA; Simelane S; Macken A; Kavanagh E; Brady JJ; McCarthy G; Compston J; Mallon PW;
AIDS; 2014 Sep; 28(14):2051-60. PubMed ID: 25265073
[TBL] [Abstract][Full Text] [Related]
12. Association between short leukocyte telomere length and HIV infection in a cohort study: No evidence of a relationship with antiretroviral therapy.
Zanet DL; Thorne A; Singer J; Maan EJ; Sattha B; Le Campion A; Soudeyns H; Pick N; Murray M; Money DM; Côté HC;
Clin Infect Dis; 2014 May; 58(9):1322-32. PubMed ID: 24457340
[TBL] [Abstract][Full Text] [Related]
13. [Study on risk factors of cardiovascular disease and the status of bone mineral density in women with hypoestrogenism].
Zhao F; Guo XT; Cheng Y; Yang ZF; Liu HP
Zhonghua Fu Chan Ke Za Zhi; 2013 Oct; 48(10):734-9. PubMed ID: 24406128
[TBL] [Abstract][Full Text] [Related]
14. The effect of telomere length, a marker of biological aging, on bone mineral density in elderly population.
Tang NL; Woo J; Suen EW; Liao CD; Leung JC; Leung PC
Osteoporos Int; 2010 Jan; 21(1):89-97. PubMed ID: 19436937
[TBL] [Abstract][Full Text] [Related]
15. Effect of antiretroviral therapy on bone turnover and bone mineral density in men with primary HIV-1 infection.
Vlot MC; Grijsen ML; Prins JM; de Jongh RT; de Jonge R; den Heijer M; Heijboer AC
PLoS One; 2018; 13(3):e0193679. PubMed ID: 29522570
[TBL] [Abstract][Full Text] [Related]
16. Frailty in HIV infected people: a new risk factor for bone mineral density loss.
Bregigeon S; Galinier A; Zaegel-Faucher O; Cano CE; Obry V; Laroche H; Trijau S; Saout A; Poizot-Martin I
AIDS; 2017 Jul; 31(11):1573-1577. PubMed ID: 28426535
[TBL] [Abstract][Full Text] [Related]
17. Identifying sex-specific risk factors for low bone mineral density in adolescent runners.
Tenforde AS; Fredericson M; Sayres LC; Cutti P; Sainani KL
Am J Sports Med; 2015 Jun; 43(6):1494-504. PubMed ID: 25748470
[TBL] [Abstract][Full Text] [Related]
18. Quantitative ultrasound and bone mineral density are equally strongly associated with risk factors for osteoporosis.
Frost ML; Blake GM; Fogelman I
J Bone Miner Res; 2001 Feb; 16(2):406-16. PubMed ID: 11204441
[TBL] [Abstract][Full Text] [Related]
19. Changes in bone mineral density over a 2-year period in HIV-1-infected men under combined antiretroviral therapy with osteopenia.
Assoumou L; Katlama C; Viard JP; Bentata M; Simon A; Roux C; Kolta S; Costagliola D; Rozenberg S;
AIDS; 2013 Sep; 27(15):2425-30. PubMed ID: 24029735
[TBL] [Abstract][Full Text] [Related]
20. Serum total estradiol, but not testosterone is associated with reduced bone mineral density (BMD) in HIV-infected men: a cross-sectional, observational study.
Santi D; Madeo B; Carli F; Zona S; Brigante G; Vescini F; Guaraldi G; Rochira V
Osteoporos Int; 2016 Mar; 27(3):1103-1114. PubMed ID: 26510848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
